Cloud-Based Informatics: A Revolution for Research

| December 12, 2018

article image
Modern-day research produces a vast amount of information. The cloud provides a solution for those drowning in this data deluge, and this infographic reviews how cloud-based solutions work and how they can benefit your research.

Spotlight

CELOGEN PHARMA PVT LTD

We would like to introduce ourselves as a new leading pharmaceutical formulations exporter/manufacturer based in India. Currently operating in some 15 countries globally we cover parts of West Africa, East Africa, South Asia, South East Asia, the Middle East & Europe. Apart from promoting our branded products in the retail sector, we also participate in a number of global tenders which are backed by the Unicef, World Bank, WHO & the local governments in a number of countries. The team comprises of a group of first generation marketing expats, who are backed up by some of the best technocrats in the field today. We have four Manufacturing Bases in Southern parts of India, manufacturing a variety of products. Our specialty however lies in the fabrication of 1st,2nd,3rd & 4th Generation Anti-biotics, ONCOLOGY Injectables, nutritional products such as Multi-Vitamins & essential oils in soft gel forms, anti-malarial & anti-TB drugs. We have also recently launched a number of higher end ant

OTHER ARTICLES

5 Pharma Trends and Their Impact on Packaging

Article | February 27, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

As Pandemic Continues, Rafael Pharmaceuticals Enrolls Patients in Phase III Pancreatic Cancer Trial

Article | April 17, 2020

That simple truth about the severity of the disease is one of the reasons that Rafael Pharmaceuticals is slowly continuing with a Phase III trial in metastatic pancreatic cancer during the COVID-19 pandemic. While many companies have paused enrollment in clinical trials during the outbreak, Cranbury, N.J,-based Rafael opted to continue to enroll patients in its Phase III AVENGER 500 study of its lead compound CPI-613 (devimistat) in combination with modified Folfirinox (mFFX) as first-line therapy for the disease. Sanjeev Luther, president and chief executive officer of Rafael Pharmaceuticals, told BioSpace that the company made the decision to continue to enroll the trial, which was 75% filled, due to the short timeline patients with metastatic pancreatic cancer have. After discussing the matter of the trial with the company’s leadership team, Luther said they felt comfortable leaving the decision of whether or not the trial should continue to the conducting institute.

Read More

Spotlight

CELOGEN PHARMA PVT LTD

We would like to introduce ourselves as a new leading pharmaceutical formulations exporter/manufacturer based in India. Currently operating in some 15 countries globally we cover parts of West Africa, East Africa, South Asia, South East Asia, the Middle East & Europe. Apart from promoting our branded products in the retail sector, we also participate in a number of global tenders which are backed by the Unicef, World Bank, WHO & the local governments in a number of countries. The team comprises of a group of first generation marketing expats, who are backed up by some of the best technocrats in the field today. We have four Manufacturing Bases in Southern parts of India, manufacturing a variety of products. Our specialty however lies in the fabrication of 1st,2nd,3rd & 4th Generation Anti-biotics, ONCOLOGY Injectables, nutritional products such as Multi-Vitamins & essential oils in soft gel forms, anti-malarial & anti-TB drugs. We have also recently launched a number of higher end ant

Events